Please login to the form below

Not currently logged in
Email:
Password:

ASBM

This page shows the latest ASBM news and features for those working in and with pharma, biotech and healthcare.

Novartis weighs in on biosimilar naming debate

Novartis weighs in on biosimilar naming debate

However, this process has been challenged in recent months by groups, such as the Alliance for Safe Biologic Medicines (ASBM), who argue that biosimilar medicines should have their own distinct scientific ... The ASBM, whose members include biologic drug

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics